263 related articles for article (PubMed ID: 10319395)
1. [Problems and prospects of beta-interferon and copaxone++ application in the treatment of multiple sclerosis].
Gusev EI; Boĭko AN; Pozer Ch
Zh Nevrol Psikhiatr Im S S Korsakova; 1999; 99(4):33-6. PubMed ID: 10319395
[No Abstract] [Full Text] [Related]
2. [A comparative analysis of rebif 22-mcg and copaxone efficacy in multiple sclerosis].
Zavalishin IA; Peresedova AV; Stoĭda NI; Rebrova Oi; Zakharova MN; Adarcheva LS; Niazbekova AS; Askarova LSh; Baĭdina EV
Zh Nevrol Psikhiatr Im S S Korsakova; 2006; Spec No 3():111-5. PubMed ID: 17172245
[TBL] [Abstract][Full Text] [Related]
3. [Possibilities and limits of immunotherapy in multiple sclerosis. Inflammatory and degenerative aspects of the disease require a new pathogenetic concept].
Kornhuber ME; Zierz S
Nervenarzt; 2003 Jun; 74(6):537-8; discussion 539. PubMed ID: 12799792
[No Abstract] [Full Text] [Related]
4. [New therapeutic agents in the management of multiple sclerosis].
Besson G; Carpentier F
Presse Med; 1998 Dec; 27(39):2032-5. PubMed ID: 9893694
[TBL] [Abstract][Full Text] [Related]
5. Immunomodulatory treatment of MS in Slovenia.
Sega-Jazbec S
Clin Neurol Neurosurg; 2002 Jul; 104(3):249-50. PubMed ID: 12127663
[No Abstract] [Full Text] [Related]
6. [Recommendations for the use of immunomodulatory drugs in multiple sclerosis: the BCTRIMS consensus] [Brazilian Committee for Treatment and Research in Multiple Sclerosis].
Tilbery CP; Moreira MA; Mendes MF; Lana-Peixoto MA
Arq Neuropsiquiatr; 2000 Sep; 58(3A):769-76. PubMed ID: 10973126
[TBL] [Abstract][Full Text] [Related]
7. [Side-effects of the treatment with disease modifying drugs in patients with multiple sclerosis: an analysis of register data in the Yaroslavl region].
Spirin NN; Kasatkin DS; Stepanov IO; Shipova EG; Baranova NS
Zh Nevrol Psikhiatr Im S S Korsakova; 2012; 112(8):27-33. PubMed ID: 23096035
[TBL] [Abstract][Full Text] [Related]
8. Differential mechanisms of action of interferon-beta and glatiramer aetate in MS.
Yong VW
Neurology; 2002 Sep; 59(6):802-8. PubMed ID: 12349849
[TBL] [Abstract][Full Text] [Related]
9. The use of interferon Beta and glatiramer acetate in multiple sclerosis.
Goodin DS
Semin Neurol; 2013 Feb; 33(1):13-25. PubMed ID: 23709209
[TBL] [Abstract][Full Text] [Related]
10. Glatiramer and suspected multiple sclerosis. No proven advantage.
Prescrire Int; 2010 Aug; 19(108):160. PubMed ID: 20941852
[No Abstract] [Full Text] [Related]
11. Newer long-term treatments for multiple sclerosis.
Pryse-Phillips W
Clin Neurol Neurosurg; 2002 Jul; 104(3):265-71. PubMed ID: 12127666
[No Abstract] [Full Text] [Related]
12. [New therapeutic methods in the treatment of multiple sclerosis].
Nervenarzt; 1996 Nov; 67(11 Suppl Neue Ther):1-12. PubMed ID: 9402424
[No Abstract] [Full Text] [Related]
13. [Pathogenesis and treatment of multiple sclerosis (state of the art in 2000)].
Zavalishin IA; Zhuchenko TD; Peresedova AV
Vestn Ross Akad Med Nauk; 2001; (7):18-22. PubMed ID: 11523422
[TBL] [Abstract][Full Text] [Related]
14. [Current concepts on the use of some immunomodulatory drugs in the treatment of multiple sclerosis].
Correale J; Cristiano E
Medicina (B Aires); 2001; 61(4):470-80. PubMed ID: 11563177
[TBL] [Abstract][Full Text] [Related]
15. Glatiramer acetate (Copaxone).
Francis DA
Int J Clin Pract; 2001; 55(6):394-8. PubMed ID: 11501229
[TBL] [Abstract][Full Text] [Related]
16. Patient and family fact sheet. Current treatments for multiple sclerosis.
Kernich CA
Neurologist; 2005 Mar; 11(2):137-8. PubMed ID: 15733335
[No Abstract] [Full Text] [Related]
17. Why treat early multiple sclerosis patients?
Comi G
Curr Opin Neurol; 2000 Jun; 13(3):235-40. PubMed ID: 10871245
[TBL] [Abstract][Full Text] [Related]
18. Disease-modifying drugs for the early treatment of multiple sclerosis.
Flachenecker P
Expert Rev Neurother; 2004 May; 4(3):455-63. PubMed ID: 15853542
[TBL] [Abstract][Full Text] [Related]
19. [Diagnostics and drug therapy of multiple sclerosis].
Suomen Neurologinen Yhdistys ry
Duodecim; 2002; 118(13):1411-23. PubMed ID: 12239889
[No Abstract] [Full Text] [Related]
20. [Drug therapy of multiple sclerosis].
Kinnunen E
Duodecim; 1999; 115(4):403-7. PubMed ID: 11830889
[No Abstract] [Full Text] [Related]
[Next] [New Search]
